Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (PIK Dividend or Equity Fee Payable) (Details)

v3.22.1
Related Party Transactions (PIK Dividend or Equity Fee Payable) (Details)
 3 Months Ended
Mar. 31, 2022
Aevitas [Member]  
Related Party Transaction [Line Items]  
Effective date Jul. 28, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Avenue [Member]  
Related Party Transaction [Line Items]  
Effective date Feb. 17, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization 0.00%
Baergic [Member]  
Related Party Transaction [Line Items]  
Effective date Dec. 17, 2019
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Cellvation [Member]  
Related Party Transaction [Line Items]  
Effective date Oct. 31, 2016
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Checkpoint [Member]  
Related Party Transaction [Line Items]  
Effective date Mar. 17, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization 0.00%
Annual equity fee as a percentage of fully diluted outstanding capitalization 2.50%
Cyprium [Member]  
Related Party Transaction [Line Items]  
Effective date Mar. 13, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Helocyte [Member]  
Related Party Transaction [Line Items]  
Effective date Mar. 20, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Mustang [Member]  
Related Party Transaction [Line Items]  
Effective date Mar. 13, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Oncogenuity [Member]  
Related Party Transaction [Line Items]  
Effective date Apr. 22, 2020
Dividends Paid in kind percentage 2.50%
UR-1 Therapeutics, Inc [Member]  
Related Party Transaction [Line Items]  
Effective date Nov. 07, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%